Point72 Asia »

Zenas Biopharma shares owned by Point72 Asia

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Point72 Asia

Quarter filed Position value Share count Share price at filing
2024-09-30 $229k 14k 16.92

More positions owned by Point72 Asia

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Wells Fargo & Company (WFC)
Medtronic SHS (MDT)
Comcast Corp Cl A (CMCSA)
Danaher Corporation (DHR)
Spotify Technology S A SHS (SPOT)
Snowflake Cl A (SNOW)
Celestica (CLS)
Adobe Systems Incorporated (ADBE)

View all positions for Point72 Asia

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma